Rheumatoid Arthritis (RA) is a chronic inflammatory disorder affecting many joints, including those in the hands and feet. The current treatment for Rheumatoid Arthritis is to target localized inflammation. This is to target the effects of the disease rather than the underlying cause of it.
Rheumatoid Arthritis Studies
- A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with anti-inflammatory properties in murine collagen-induced arthritis
- Cannabinoids as novel anti-inflammatory drugs
- Cannabinoids: novel therapies for arthritis?
- Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
- Characterization of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
- Preliminary assessment of the efficacy, tolerability, and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
- The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
- Transdermal cannabidiol reduces inflammation and pain-related behaviors in a rat model of arthritis